Endoscopic Options for Gastroesophageal Reflux: Where Are We Now and What Does the Future Hold?

被引：8
作者：
Triadafilopoulos G. [1 ]
机构：
[1] Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 300 Pasteur Drive, M-211, Stanford, 94306, CA
来源：
Current Gastroenterology Reports | 2016年 / 18卷 / 9期
关键词：
Endoscopic anti-reflux therapy (EART); Endoscopy; Gastroesophageal reflux disease (GERD); Laparoscopy; Minimally invasive solutions; Proton pump inhibitor;
D O I：
10.1007/s11894-016-0521-1
中图分类号：
学科分类号：
摘要：
Early in the twenty-first century, novel endoscopic techniques were introduced for the management of gastroesophageal reflux disease, providing minimally invasive ways to eliminate pharmacologic acid inhibition and avoid the need for anti-reflux surgery. These techniques do not significantly alter the anatomy of the gastroesophageal junction, minimizing short- and long-term adverse effects, such as dysphagia and bloating. After extensive clinical testing, many endoscopic therapies were abandoned due to either lack of durable efficacy or unfavorable safety profile. Today, only four such therapies remain clinically available, each with variable levels of clinical validation and market penetration. This review will provide an assessment of these endoscopic therapies, highlighting their respective strengths and weaknesses and their present and future applicability to patients with gastroesophageal reflux disease. © 2016, Springer Science+Business Media New York.
引用
收藏
相关论文
共 42 条
[21]  
Liang W.T., Wu J.M., Hu Z.W., Wang Z.G., Zhu G.C., Zhang C., Laparoscopic Nissen fundoplication is more effective in treating patients with GERD-related chronic cough than Stretta radiofrequency, Minerva Chir, 69, 3, pp. 121-127, (2014)
[22]  
Hu Z., Wu J., Wang Z., Zhang Y., Liang W., Yan C., Outcome of Stretta radiofrequency and fundoplication for GERD-related severe asthmatic symptoms, Front Med, 9, 4, pp. 437-443, (2015)
[23]  
Noar M., Squires P., Noar E., Lee M., Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later, Surg Endosc, 28, 8, pp. 2323-2333, (2014)
[24]  
Funk L.M., Zhang J.Y., Drosdeck J.M., Melvin W.S., Walker J.P., Perry K.A., Long-term cost-effectiveness of medical, endoscopic and surgical management of gastroesophageal reflux disease, Surgery, 157, 1, pp. 126-136, (2015)
[25]  
Lipka S., Kumar A., Richter J.E., No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 13, 6, pp. 67-1058, (2015)
[26]  
Hakansson B., Montgomery M., Cadiere G.B., Rajan A., Bruley des Varannes S., Lerhun M., Et al., Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD, Aliment Pharmacol Ther, 42, 11-12, pp. 1261-1270, (2015)
[27]  
Witteman B.P., Conchillo J.M., Rinsma N.F., Betzel B., Peeters A., Koek G.H., Et al., Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease, Am J Gastroenterol, 110, 4, pp. 531-542, (2015)
[28]  
Hunter J.G., Kahrilas P.J., Bell R.C., Wilson E.B., Trad K.S., Dolan J.P., Et al., Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial, Gastroenterology, 148, 2, pp. 324-334, (2015)
[29]  
Trad K.S., Simoni G., Barnes W.E., Shughoury A.B., Raza M., Heise J.A., Et al., Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study, BMC Gastroenterol, 14, (2014)
[30]  
Trad K.S., Barnes W.E., Simoni G., Shughoury A.B., Mavrelis P.G., Raza M., Et al., Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial, Surg Innov, 22, 1, pp. 26-40, (2015)
12345